X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Panacea Biotec Ltd.
BSE CODE: 531349   |   NSE CODE: PANACEABIO   |   ISIN CODE : INE922B01023   |   21-Nov-2024 Hrs IST
BSE NSE
Rs. 414.75
19.15 ( 4.84% )
 
Prev Close ( Rs.)
395.60
Open ( Rs.)
415.35
 
High ( Rs.)
415.35
Low ( Rs.)
380.15
 
Volume
84729
Week Avg.Volume
41658
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 414.00
19.7 ( 5% )
 
Prev Close ( Rs.)
394.30
Open ( Rs.)
414.00
 
High ( Rs.)
414.00
Low ( Rs.)
395.00
 
Volume
358735
Week Avg.Volume
144887
 
52 WK High-Low Range(Rs.)
112.35
414
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)0.58  -14.29  -15.28  -2.35  -24.99  
   CEPS(Rs)4.02  -10.29  -10.96  1.98  -20.54  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)53.74  53.17  67.77  82.97  140.53  
   Tax Rate(%)15.60  -39.51  0.00  -12.15  -12.58  
Margin Ratios          
   Core EBITDA Margin(%)3.93  -24.21  -30.75  0.14  1.96  
   EBIT Margin(%)4.99  -20.36  -36.62  -1.53  2.20  
   Pre Tax Margin(%)1.17  -24.25  -39.60  -3.69  -26.57  
   PAT Margin (%)0.98  -33.84  -39.60  -4.14  -29.92  
   Cash Profit Margin (%)6.84  -24.37  -28.41  3.49  -24.58  
Performance Ratios          
   ROA(%)0.39  -9.57  -9.88  -1.27  -10.56  
   ROE(%)1.08  -23.64  -20.27  -2.11  -23.93  
   ROCE(%)4.08  -11.36  -16.14  -0.70  1.09  
   Asset Turnover(x)0.40  0.28  0.25  0.31  0.35  
   Sales/Fixed Asset(x)0.43  0.30  0.28  0.41  0.52  
   Working Capital/Sales(x)-5.48  -5.00  50.58  5.99  1.14  
Efficiency Ratios          
   Fixed Capital/Sales(x)2.33  3.32  3.58  2.43  1.91  
   Receivable days11.82  25.11  45.26  27.77  15.29  
   Inventory Days113.44  173.06  167.03  97.64  50.55  
   Payable days324.34  306.74  437.99  269.16  258.86  
Valuation Parameters          
   PER(x)209.28  0.00  0.00  0.00  0.00  
   PCE(x)30.16  -10.53  -13.52  89.37  -5.33  
   Price/Book(x)2.26  2.04  2.19  2.14  0.78  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)2.33  2.81  4.03  3.09  1.38  
   EV/Core EBITDA(x)21.46  -25.64  -15.80  50.04  12.55  
   EV/EBIT(x)46.61  -13.72  -10.97  -199.19  60.07  
   EV/CE(x)1.85  1.69  1.02  1.10  0.52  
   M Cap / Sales2.07  2.58  3.86  3.16  1.37  
Growth Ratio          
   Net Sales Growth(%)39.89  9.16  -31.45  -29.84  10.25  
   Core EBITDA Growth(%)238.60  53.09  -383.02  -60.64  138.96  
   EBIT Growth(%)134.14  39.11  -1521.99  -147.32  -92.05  
   PAT Growth(%)104.06  6.45  -549.25  90.58  -676.10  
   EPS Growth(%)104.06  6.45  -549.25  90.58  -676.09  
Financial Stability Ratios          
   Total Debt/Equity(x)0.38  0.31  0.20  0.13  0.08  
   Current Ratio(x)0.74  0.79  1.02  1.29  3.67  
   Quick Ratio(x)0.30  0.33  0.49  0.85  3.08  
   Interest Cover(x)1.31  -5.24  -12.29  -0.71  0.08  
   Total Debt/Mcap(x)0.17  0.15  0.09  0.06  0.10